Drug:
Reaction: TREMOR
20260101 - 20261231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 26804242 |
CA |
80 | 1 |
Aspartate aminotransferase increased, Vomiting, Blood phosphorus increased, Sepsis, Lung disorder, Hypertension, Lower respiratory tract infection, Neuralgia, Headache, Ventricular fibrillation, Product dose omission issue, Drug intolerance, Activated partial thromboplastin time prolonged, Asthenia, Appendicolith, Ascites, Respiratory symptom, Incorrect route of product administration, Constipation, Liver disorder, Analgesic therapy, Pulmonary embolism, Joint injury, Congenital hiatus hernia, Transient ischaemic attack, Dry mouth, General physical health deterioration, Hyponatraemia, Anticoagulant therapy, Iron deficiency, Nausea, Blood cholesterol increased, Upper respiratory tract infection, Dyspnoea, Blood uric acid increased, Coronary artery disease, Anaemia, Benign prostatic hyperplasia, Full blood count abnormal, Hyperphosphataemia, Blood test abnormal, Musculoskeletal stiffness, Sleep disorder, Tremor, Antacid therapy, Bacterial infection, Condition aggravated, Gastrointestinal disorder, Malignant melanoma stage 0, Hypercholesterolaemia, Aortic stenosis, Myasthenia gravis, Drug ineffective, Ulcer, Fatigue, Stress, Bronchopulmonary aspergillosis allergic, Abdominal distension, Drug therapy, Intentional product misuse, Chronic obstructive pulmonary disease, Off label use, Swelling, Pleuritic pain, End stage renal disease, Sleep disorder therapy, Cardiogenic shock, Abdominal pain, Product use in unapproved indication, Multiple organ dysfunction syndrome, Breath sounds abnormal, Hyperlipidaemia, Somnolence, Asthma, Diabetes mellitus, Drug hypersensitivity, Troponin increased, Blood calcium increased, Oedema peripheral, Micturition urgency, Cardiovascular disorder, Blood creatinine increased, Appendicitis, Gout, Pain, Transaminases increased, Hypophosphataemia, Thrombosis, Aspiration, Pyrexia, Intentional product misuse, |
||||
AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, DALTEPARIN SODIUM, DALTEPARIN SODIUM, DEXLANSOPRAZOLE, DALTEPARIN SODIUM, DALTEPARIN SODIUM, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MEPOLIZUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DARBEPOETIN ALFA, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, |
||||
| 702 | 26804386 |
GB |
2 | |
Unresponsive to stimuli, Hot flush, Hyperventilation, Pollakiuria, Tremor, Abdominal distension, Malaise, Fatigue, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 703 | 26804445 |
US |
43 | 2 |
Gingival bleeding, Tremor, Muscle spasms, Blood potassium decreased, Injection site bruising, Injection site pain, Product use in unapproved indication, |
||||
CAPLACIZUMAB, CAPLACIZUMAB, CAPLACIZUMAB, CAPLACIZUMAB, |
||||
| 704 | 26804835 |
JP |
5 | 2 |
Suicide attempt, Toxicity to various agents, Dyspnoea, Agitation, Hyperhidrosis, Muscle spasms, Creatine kinase increased, Blood lactic acid increased, Tremor, Vomiting, Sinus tachycardia, Intentional overdose, |
||||
CAFFEINE, PAROXETINE HYDROCHLORIDE, LURASIDONE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, CLONAZEPAM, ZOLPIDEM TARTRATE, VALPROATE SODIUM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 705 | 26804845 |
KW |
47 | 2 |
Tremor, Asthenia, Drug intolerance, Hypophagia, Mental disorder, Heart rate increased, |
||||
UPADACITINIB, |
||||
| 706 | 26804997 |
US |
72 | 2 |
Tremor, |
||||
DONANEMAB-AZBT, |
||||
| 707 | 26805014 |
US |
78 | 1 |
Tremor, Cerebrovascular accident, Hallucination, auditory, Dyskinesia, Somnolence, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 708 | 26805095 |
EU |
38 | 2 |
Cerebral atrophy, Dysaesthesia, Sleep disorder, Drug abuse, Tremor, Nausea, Tachycardia, |
||||
ZOLPIDEM TARTRATE, |
||||
| 709 | 26805634 |
US |
||
Feeling abnormal, Tremor, Abdominal pain, |
||||
BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, |
||||
| 710 | 26805796 |
EU |
2 | |
Suicide attempt, Delusion, Hallucination, Poor quality sleep, Alopecia, Irritability, Loss of personal independence in daily activities, Somnolence, Dry mouth, Nightmare, Tremor, |
||||
QUETIAPINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LITHIUM, LITHIUM BROMATUM, |
||||
| 711 | 26805913 |
US |
73 | 2 |
Arrhythmia, Hypertensive crisis, Tremor, Dysphonia, Blood pressure systolic increased, Drug intolerance, |
||||
ALBUTEROL SULFATE, AMIKACIN, |
||||
| 712 | 26805927 |
EU |
2 | |
Suicide attempt, Loss of personal independence in daily activities, Hallucination, Poor quality sleep, Delusion, Dry mouth, Somnolence, Tremor, Nightmare, Irritability, Alopecia, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, QUETIAPINE, LITHIUM, LITHIUM BROMATUM, |
||||
| 713 | 26806098 |
EU |
41 | 2 |
Disturbance in attention, Tremor, Visual impairment, Decreased appetite, Faeces discoloured, Food aversion, Dizziness, Asthenia, Flatulence, Abdominal distension, Diarrhoea, Nausea, Vomiting, Cyst, Nephrolithiasis, Uterine leiomyoma, |
||||
TIRZEPATIDE, |
||||
| 714 | 26806864 |
CA |
70 | 2 |
Drug hypersensitivity, Dysarthria, Cerebrovascular accident, Head discomfort, Ear pruritus, Blood pressure increased, Dysphemia, Respiratory rate increased, Anxiety, Chills, Trismus, Near death experience, Tremor, |
||||
RITUXIMAB-PVVR, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 715 | 26807154 |
2 | ||
Tremor, Therapy interrupted, |
||||
POMALIDOMIDE, |
||||
| 716 | 26807233 |
66 | 2 | |
Expired product administered, Tremor, |
||||
| 717 | 26807635 |
US |
83 | 1 |
Pain, Vomiting, Moaning, Screaming, Chills, Tremor, |
||||
HUMAN IMMUNOGLOBULIN G, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 718 | 26807807 |
CN |
75 | 2 |
Tremor, Nausea, Vomiting, |
||||
DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE, |
||||
| 719 | 26808904 |
BR |
71 | 2 |
Bone loss, Haematochezia, Gastrointestinal inflammation, Venous occlusion, Cataract, Post procedural haemorrhage, Anxiety, Tremor, Drug ineffective, |
||||
RISANKIZUMAB-RZAA, CLOPIDOGREL, CLOPIDOGREL BISULFATE, HYDROCHLOROTHIAZIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 720 | 26798489 |
US |
22 | |
Hypoaesthesia, Musculoskeletal chest pain, Tremor, Tachycardia, Hypertension, Maternal exposure during pregnancy, |
||||
NIFEDIPINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LABETALOL, |
||||
| 721 | 26798658 |
US |
61 | 2 |
Speech disorder, Tremor, |
||||
LUMATEPERONE, |
||||
| 722 | 26799190 |
CA |
53 | |
Disability, Tremor, Drooling, |
||||
LITHIUM, LITHIUM BROMATUM, |
||||
| 723 | 26799501 |
US |
75 | 1 |
Illness, Abdominal pain, Therapeutic product effect incomplete, Disease risk factor, Tremor, Oxygen saturation decreased, Lung disorder, Fall, Influenza, Concussion, Head injury, Dysstasia, Gait inability, |
||||
UPADACITINIB, UPADACITINIB, PSYLLIUM HUSK, |
||||
| 724 | 26799524 |
US |
2 | |
Exposure during pregnancy, Tremor, Anxiety, Fatigue, Therapeutic product effect prolonged, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 725 | 26799525 |
US |
||
Vision blurred, Diarrhoea, Anxiety, Steatorrhoea, Gastrooesophageal reflux disease, Abdominal pain upper, Blepharospasm, Tremor, Abdominal pain, Blood pressure increased, Heart rate increased, Nausea, Insomnia, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 726 | 26799548 |
BR |
26 | 2 |
Lip swelling, Vision blurred, Blood pressure decreased, Dyspnoea, Urticaria, Tremor, |
||||
IRON, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 727 | 26799991 |
US |
77 | 2 |
Impaired quality of life, Tremor, |
||||
DUPILUMAB, VITAMIN E, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, MAGNESIUM OXIDE, SACUBITRIL AND VALSARTAN, ENSIFENTRINE, |
||||
| 728 | 26800049 |
EU |
13 | 2 |
Disease recurrence, Weight increased, Akathisia, Tremor, Sedation, |
||||
RISPERIDONE, RISPERIDONE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CLOZAPINE, |
||||
| 729 | 26800139 |
US |
2 | |
Tremor, Dizziness, Ligament rupture, Hypoaesthesia, Wrist fracture, Fall, Back pain, Musculoskeletal chest pain, |
||||
ASFOTASE ALFA, TERIPARATIDE, |
||||
| 730 | 26800518 |
BR |
53 | |
Graft versus host disease, Neutropenia, Febrile neutropenia, Tremor, Hypercalcaemia, Hyperhidrosis, |
||||
LENALIDOMIDE, METHOTREXATE SODIUM, CYTARABINE, |
||||
| 731 | 26800891 |
2 | ||
Diarrhoea, Nausea, Arthralgia, Back pain, Tremor, Bone pain, Gait disturbance, |
||||
POMALIDOMIDE, |
||||
| 732 | 26800927 |
CA |
2 | |
Tremor, Fall, Shoulder fracture, Haemorrhage intracranial, |
||||
ZOLEDRONIC ACID, |
||||
| 733 | 26801032 |
CA |
76 | 2 |
Chills, Drug hypersensitivity, Feeling abnormal, Headache, Malaise, Nausea, Platelet count decreased, Tremor, Incorrect dose administered, |
||||
CYCLOSPORINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ELTROMBOPAG OLAMINE, ELTROMBOPAG, CEFACLOR, MICONAZOLE, MICONAZOLE NITRATE, TRIMETHOPRIM, BISOPROLOL FUMARATE, VITAMIN C, AMLODIPINE, |
||||
| 734 | 26801050 |
US |
2 | |
Hallucination, Weight increased, Fatigue, Muscle spasms, Malaise, Back pain, Tremor, Anxiety, Dyskinesia, Joint injury, Head injury, Nausea, Fall, Condition aggravated, Abdominal discomfort, Somnolence, Drug intolerance, Underdose, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, CLOZAPINE, |
||||
| 735 | 26801353 |
GB |
||
Sleep attacks, Tremor, Migraine, Hot flush, Illness, Dizziness, Fatigue, Nasopharyngitis, |
||||
ROPINIROLE, PROPRANOLOL HYDROCHLORIDE, QUININE, |
||||
| 736 | 26801438 |
EU |
71 | |
Agranulocytosis, Thrombocytopenia, Encephalopathy, Cytomegalovirus infection reactivation, Toxic epidermal necrolysis, Echolalia, Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Tremor, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 737 | 26801484 |
US |
||
Seizure like phenomena, Tremor, Drug ineffective, Product quality issue, |
||||
ETOMIDATE, ETOMIDATE INJECTION, ETOMIDATE, ETOMIDATE INJECTION, |
||||
| 738 | 26801554 |
78 | 2 | |
Tremor, Agitation, Insomnia, Swelling face, Erythema, Blood pressure increased, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 739 | 26801917 |
BR |
73 | 2 |
Tremor, Chills, Tachycardia, |
||||
RITUXIMAB-PVVR, CHLORAMBUCIL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 740 | 26802071 |
KR |
1 | |
End stage renal disease, Metastases to central nervous system, Headache, Tremor, |
||||
DURVALUMAB, |
||||
| 741 | 26802093 |
73 | 1 | |
Chills, Hyperpyrexia, Tremor, Suspected off label use, |
||||
POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 742 | 26802095 |
US |
8 | 2 |
Musculoskeletal stiffness, Muscle strength abnormal, General physical condition abnormal, Pain, Tremor, Arthralgia, Myalgia, Muscle spasms, Pain in extremity, Rash, |
||||
DENOSUMAB, ZOLEDRONIC ACID, CALCIUM, ERGOCALCIFEROL, ACETAMINOPHEN, ASPRIN, CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE, ACETAMINOPHEN, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, CAFFEINE, |
||||
| 743 | 26802281 |
US |
45 | 2 |
Throat irritation, Tremor, |
||||
OCRELIZUMAB, |
||||
| 744 | 26802611 |
US |
70 | 2 |
Tremor, |
||||
PALOPEGTERIPARATIDE, PROPRANOLOL HYDROCHLORIDE, ORAL SEMAGLUTIDE, PANTOPRAZOLE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, EVOLOCUMAB, BUPROPION, |
||||
| 745 | 26802703 |
US |
70 | 2 |
Abdominal distension, Rash, Night sweats, Increased appetite, Weight increased, Pruritus, Tremor, Blister, |
||||
OLANZAPINE, OLANZAPINE, OLANZAPINE, LORAZEPAM, TEMAZEPAM, PROPRANOLOL HYDROCHLORIDE, METHADONE, PRAMIPEXOLE, |
||||
| 746 | 26802822 |
EU |
1 | |
Altered state of consciousness, Stereotypy, Poverty of speech, Food refusal, Tremor, Product use in unapproved indication, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 747 | 26802854 |
EU |
77 | 1 |
Fatigue, Tremor, Hyperkinesia, Freezing phenomenon, |
||||
| 748 | 26802991 |
EU |
28 | 1 |
Cardiovascular disorder, Vertigo, Hyperhidrosis, Muscular weakness, Tremor, Presyncope, Circulatory collapse, Loss of personal independence in daily activities, Hypotonia, Labelled drug-drug interaction issue, Skin odour abnormal, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, PANTOPRAZOLE, |
||||
| 749 | 26803252 |
US |
1 | |
Drug abuse, Drug diversion, Decreased eye contact, Hypertension, Nervousness, Tremor, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, FENTANYL, |
||||
| 750 | 26803290 |
45 | 2 | |
Tremor, Cold sweat, Intentional dose omission, Suspected off label use, |
||||
FINERENONE, |
||||
| 751 | 26803482 |
US |
||
Tremor, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
| 752 | 26803556 |
EU |
1 | |
Knee operation, On and off phenomenon, Arthralgia, Mobility decreased, Hallucination, Infusion site pain, Infusion site haematoma, Incorrect product administration duration, Tremor, Musculoskeletal stiffness, Tooth infection, Infusion site induration, Drug ineffective, |
||||
FOSCARBIDOPA/FOSLEVODOPA, OPICAPONE, MELATONIN, RIVAROXABAN, TORSEMIDE, QUETIAPINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MIDODRINE HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, RAMIPRIL, |
||||
| 753 | 26806297 |
71 | 2 | |
Vomiting, Hypertension, Feeling cold, Tremor, Dyskinesia, Headache, Wrong product administered, Epinephrine increased, Oxygen saturation decreased, |
||||
EPINEPHRINE, ADRENALINUM, GABAPENTIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, IRON, MAGNESIUM, |
||||
| 754 | 26806300 |
1 | ||
Pyrexia, Infection, Atrial fibrillation, Tremor, Intentional dose omission, Therapy change, |
||||
LENALIDOMIDE, DAPAGLIFLOZIN, GABAPENTIN, MELOXICAM, INSULIN GLARGINE, |
||||
| 755 | 26806570 |
31 | 1 | |
Tremor, Sleep disorder, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 756 | 26806571 |
39 | 2 | |
Pruritus, Feeling hot, Coma, Unresponsive to stimuli, Tremor, Blood pressure increased, Discomfort, Muscle spasms, Feeling abnormal, Muscle spasms, |
||||
PAROXETINE HYDROCHLORIDE, PREDNISONE, DIAZEPAM, |
||||
| 757 | 26793853 |
US |
44 | 2 |
Toxicity to various agents, Social avoidant behaviour, Abnormal behaviour, Amnesia, Tremor, Asthenia, Decreased appetite, Vomiting, Drug interaction, |
||||
LITHIUM CARBONATE, NORGESTIMATE AND ETHINYL ESTRADIOL, FAMOTIDINE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, GABAPENTIN, HYDROXYZINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE, QUETIAPINE, TIRZEPATIDE, ZOLPIDEM TARTRATE, |
||||
| 758 | 26794063 |
EU |
74 | 1 |
Tachycardia, Hypertension, Chills, Tremor, Oxygen saturation decreased, |
||||
| 759 | 26794066 |
US |
||
Agitation, Tremor, Disorientation, Speech disorder, Muscle spasms, Catatonia, Off label use, |
||||
RITUXIMAB, GLOFITAMAB, OBINUTUZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 760 | 26794135 |
GB |
2 | |
Hot flush, Tremor, Unresponsive to stimuli, Abdominal distension, Malaise, Pollakiuria, Fatigue, Hyperventilation, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 761 | 26794315 |
EU |
24 | 1 |
Altered state of consciousness, Food refusal, Poverty of speech, Stereotypy, Tremor, Product use in unapproved indication, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, LORAZEPAM, LORAZEPAM, LORAZEPAM, LORAZEPAM, OLANZAPINE, OLANZAPINE, FLUMAZENIL, |
||||
| 762 | 26794408 |
US |
2 | |
Parkinson^s disease, Tremor, Dyskinesia, Therapeutic product effect variable, Drug ineffective, |
||||
LEVODOPA, LEVODOPA, ENTACAPONE, FUROSEMIDE, LEFLUNOMIDE, ESCITALOPRAM, PREGABALIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PRAMIPEXOLE, RALOXIFENE, SERTRALINE, CARBIDOPA AND LEVODOPA, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALPRAZOLAM, |
||||
| 763 | 26794560 |
EU |
14 | 2 |
Self-destructive behaviour, Hyperhidrosis, Palpitations, Tremor, Temperature regulation disorder, |
||||
SERTRALINE, |
||||
| 764 | 26794610 |
US |
54 | |
Drug withdrawal syndrome, Tremor, Abdominal discomfort, Diarrhoea, Drug ineffective, Therapeutic product effect variable, |
||||
OXYCODONE, |
||||
| 765 | 26794630 |
US |
49 | |
Drug withdrawal syndrome, Irritability, Feeling jittery, Tremor, Pain, Food poisoning, Drug ineffective, |
||||
OXYCODONE, OXYCODONE, LISINOPRIL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 766 | 26794647 |
US |
69 | |
Drug withdrawal syndrome, Tremor, Hyperhidrosis, Irritability, Nausea, Abdominal discomfort, Emotional distress, Screaming, Drug ineffective, Product physical issue, Product dose omission issue, |
||||
OXYCODONE, |
||||
| 767 | 26794777 |
69 | 1 | |
Rebound effect, Tremor, Cognitive disorder, Fatigue, Therapy non-responder, Treatment failure, Drug effective for unapproved indication, Off label use, |
||||
GABAPENTIN, GABAPENTIN, TOPIRAMATE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PRIMIDONE, PRIMIDONE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, METHAZOLAMIDE, METHAZOLAMIDE, ZONISAMIDE, |
||||
| 768 | 26795070 |
US |
81 | 1 |
Parkinson^s disease, Dementia with Lewy bodies, Cardiac disorder, Hallucination, Hallucination, visual, Condition aggravated, Musculoskeletal stiffness, Mobility decreased, Lethargy, Fluid intake reduced, Joint swelling, Dysphagia, Amnesia, Mood swings, Obsessive thoughts, Disturbance in attention, Disorientation, Muscle rigidity, Balance disorder, Orthostatic hypotension, Malaise, Loss of personal independence in daily activities, Saliva altered, Tremor, Dizziness, Bowel movement irregularity, Dysphonia, Fall, Constipation, Somnolence, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LATANOPROST, POLYETHYLENE GLYCOL 3350, PSYLLIUM HUSK, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, RIVASTIGMINE, INCOBOTULINUMTOXINA, CARBIDOPA AND LEVODOPA, |
||||
| 769 | 26795207 |
79 | 1 | |
Death, Tremor, |
||||
OPICAPONE, |
||||
| 770 | 26795389 |
US |
69 | 1 |
Tremor, Product ineffective for unapproved use, Off label use, Fatigue, Cognitive disorder, |
||||
TOPIRAMATE, PROPRANOLOL HYDROCHLORIDE, GABAPENTIN, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, METHAZOLAMIDE, PRIMIDONE, ZONISAMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PREDNISONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, |
||||
| 771 | 26795412 |
US |
54 | 1 |
Tremor, Drug ineffective, Neuropathy peripheral, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, CEFTRIAXONE, CEFTRIAXONE SODIUM, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MEROPENEM, VORICONAZOLE, VORICONAZOLE INJECTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 772 | 26795545 |
US |
2 | |
Drug ineffective, Tremor, |
||||
XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, |
||||
| 773 | 26795710 |
EU |
79 | 1 |
Mental status changes, Tremor, Urinary retention, Dry mouth, |
||||
SERTRALINE, MIRABEGRON, EDOXABAN TOSYLATE, EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, GLIMEPIRIDE, FOLIC ACID, |
||||
| 774 | 26795765 |
EU |
60 | 2 |
Tremor, Hyperhidrosis, Anxiety, Palpitations, Drug interaction, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, BUPROPION HYDROCHLORIDE, PREGABALIN, PREGABALIN, ALPRAZOLAM, |
||||
| 775 | 26796741 |
GB |
||
Tremor, Migraine, Feeling hot, Illness, Dizziness, Fatigue, Sleep attacks, Nasopharyngitis, |
||||
ROPINIROLE, PROPRANOLOL HYDROCHLORIDE, QUININE, |
||||
| 776 | 26796774 |
0 | 1 | |
Infantile spasms, Screaming, Crying, Abnormal behaviour, Tremor, Somnolence, |
||||
VIGABATRIN, |
||||
| 777 | 26797232 |
CN |
9 | 1 |
Phantom limb syndrome, Palpitations, Tremor, Product administered to patient of inappropriate age, Product use in unapproved indication, |
||||
MONTELUKAST SODIUM, |
||||
| 778 | 26797267 |
US |
82 | 1 |
Parkinson^s disease, Dyskinesia, Tremor, |
||||
BREXPIPRAZOLE, |
||||
| 779 | 26797480 |
US |
||
Urinary retention, Benign neoplasm, Bone pain, Fatigue, Hypoaesthesia, Paraesthesia, Aphasia, Memory impairment, Tremor, Vision blurred, Dysphagia, |
||||
ASFOTASE ALFA, |
||||
| 780 | 26797557 |
18 | ||
Seizure, Gastrointestinal tube insertion, Mitral valve thickening, Tremor, Dizziness, Decreased appetite, Weight decreased, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, CLONAZEPAM, VALPROIC ACID, |
||||
| 781 | 26797626 |
US |
28 | 2 |
Flushing, Dyspnoea, Chills, Tremor, Arthralgia, COVID-19, Panic attack, |
||||
ASFOTASE ALFA, GLUTATHIONE, KOJIC ACIDSKIN LIGHTENING, FISH OIL, DIPHENHYDRAMINE HYDROCHLORIDE, MELATONIN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 782 | 26797647 |
US |
73 | 2 |
Vision blurred, Dizziness, Dysgeusia, Nausea, Hypophagia, Tremor, Gait disturbance, |
||||
LENALIDOMIDE, BORTEZOMIB, DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 783 | 26797752 |
US |
60 | 2 |
Tremor, Nausea, Fatigue, |
||||
TIRZEPATIDE, |
||||
| 784 | 26798005 |
JP |
81 | 2 |
Scleroderma, Syncope, Weight decreased, Fall, Constipation, Nausea, Tremor, Product dose omission issue, Physical deconditioning, Blood pressure increased, Blood pressure increased, Decreased appetite, Dry mouth, Dehydration, Labile blood pressure, Headache, Dizziness, Dry eye, |
||||
DAPAGLIFLOZIN, |
||||
| 785 | 26798045 |
77 | 1 | |
Oedema genital, Tremor, |
||||
EDOXABAN TOSYLATE, TOLVAPTAN, SPIRONOLACTONE, SACUBITRIL AND VALSARTAN, |
||||
| 786 | 26798266 |
EU |
67 | 2 |
Seizure, Dyskinesia, Tremor, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 787 | 26798294 |
EU |
80 | 2 |
Cerebrovascular accident, Oropharyngeal discomfort, Restlessness, On and off phenomenon, Catheter site related reaction, Therapeutic product effect decreased, Catheter site bruise, Device difficult to use, Loss of personal independence in daily activities, Fluid intake reduced, Tremor, Gait disturbance, Muscle spasms, Injection site inflammation, Musculoskeletal stiffness, Injection site reaction, Product dose omission in error, Hypophagia, Anxiety, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, AMLODIPINE, CANDESARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PRAMIPEXOLE, |
||||
| 788 | 26807738 |
|||
Apgar score low, Blood pressure increased, Heart rate, Tremor, Seizure, Irritability, Poor feeding infant, Body temperature increased, |
||||
CARIPRAZINE, CARIPRAZINE, |
||||
| 789 | 26793327 |
US |
||
Tremor, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 790 | 26802408 |
46 | 2 | |
Feeling jittery, Palpitations, Tachycardia, Muscle spasms, Tremor, Flank pain, Poor quality sleep, Feeling abnormal, |
||||
BISACODYL, |
||||
| 791 | 26792264 |
US |
61 | 1 |
Musculoskeletal stiffness, Tremor, Drug intolerance, |
||||
CARBIDOPA AND LEVODOPA, |
||||
| 792 | 26792274 |
US |
66 | 2 |
Tremor, Drug ineffective, Therapeutic response shortened, |
||||
GABAPENTIN, |
||||
| 793 | 26792282 |
US |
1 | |
Tremor, Rash, Pruritus, Drug intolerance, Insomnia, |
||||
| 794 | 26792291 |
US |
77 | 2 |
Tremor, Product use issue, Product dose omission issue, |
||||
| 795 | 26792298 |
US |
64 | 2 |
Tremor, Insomnia, Product use issue, |
||||
LOSARTAN, |
||||
| 796 | 26792320 |
US |
||
Blood pressure abnormal, Tremor, Balance disorder, Fall, |
||||
| 797 | 26792337 |
US |
||
Tremor, |
||||
| 798 | 26792344 |
US |
||
Tremor, Drug effect less than expected, |
||||
| 799 | 26792346 |
US |
||
Tremor, Freezing phenomenon, Dyskinesia, Treatment noncompliance, |
||||
| 800 | 26792359 |
US |
79 | 1 |
Gait disturbance, Tremor, Visual impairment, Product substitution issue, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
